Skip to content

Clinical trials

Completed Observational Cardiotoxicity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Phase: Observational Status: Completed Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20084
20101
20114
20132
20144
20153
20162
20174
20182
20192
20206
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Groupe Hospitalier Pitie-Salpetriere4
Abramson Cancer Center at Penn Medicine3
Istanbul University3
A.O.U. Città della Salute e della Scienza1
AHS Cancer Control Alberta1
Air Force Military Medical University, China1
Assistance Publique - Hôpitaux de Paris1
Barts & The London NHS Trust1
Cancer Trials Ireland1
Connecticut Children's Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity43
Breast Neoplasms12
Heart Failure9
Neoplasms7
Lymphoma6
Heart Diseases4
Cardiomyopathies3
Cardiovascular Diseases3
Lung Neoplasms3
Lymphoma, Non-Hodgkin3

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.